← Back to Search

A4i Intervention for Psychosis

N/A

Waitlist Available

Research Sponsored by Centre for Addiction and Mental Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 27 months.

Awards & highlights

No Placebo-Only Group

Summary

This trial tests a new app called App4Independence (A4i) designed to help people with schizophrenia manage their symptoms and stay on their treatment plans. The app provides reminders, coping tips, and ways to connect with peers and healthcare providers. The goal is to see if this app can improve treatment engagement and reduce hospital readmissions for people with schizophrenia.

Eligible Conditions

Psychosis
Schizophrenia
Schizoaffective Disorder

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 27 months.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~27 months.

This trial's timeline: 3 weeks for screening, Varies for treatment, and 27 months. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Incidence of Treatment-Emergent Adverse Events

Objective App Use

Recruitment

+1 more

Secondary study objectives

App Strengths and Limitations

Appointment Attendence

Clinical Alliance

+6 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: A4i InterventionExperimental Treatment1 Intervention

App4Independence (A4i) Experimental: A4i Intervention App4Independence (A4i) The study intervention is the digital health platform A4i. A4i operates on the individual's own phone with or without data. Specific A4i functionality includes: * Addressing social isolation and cognitive challenges through personalized prompts, scheduling of activities, and connections to a range of resources. * Fostering illness self-management through evidence-informed content. * A peer-peer engagement platform that facilitates strategy/tip sharing between users (anonymous and moderated). * Daily wellness and goal attainment check-ins. * An ambient sound detector with an oscilloscope-type indicator that assists individuals with auditory hallucinations separate hallucinations from real sounds. * Passively collected data on phone use as a proxy for sleep. * A provider dashboard. Both control and experimental condition participants will be receiving standard outpatient care (TAU).

Group II: Treatment As UsualActive Control1 Intervention

Treatment as usual participants will be recieving outpatient mental health care through the standard supports (most typically, case management and psychiatric support) that are available in a large, Canadian, urban centre.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

A4i Intervention

2021

N/A

~90

Do I qualify?Apply below to find out